» Articles » PMID: 38992634

Association Between Triglyceride Glucose-waist Height Ratio Index and Cardiovascular Disease in Middle-aged and Older Chinese Individuals: a Nationwide Cohort Study

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The triglyceride-glucose (TyG) index and its combination with obesity indicators can predict cardiovascular diseases (CVD). However, there is limited research on the relationship between changes in the triglyceride glucose-waist height ratio (TyG-WHtR) and CVD. Our study aims to investigate the relationship between the change in the TyG-WHtR and the risk of CVD.

Methods: Participants were from the China Health and Retirement Longitudinal Study (CHARLS). CVD was defined as self-reporting heart disease and stroke. Participants were divided into three groups based on changes in TyG-WHtR using K-means cluster analysis. Multivariable binary logistic regression analysis was used to examine the association between different groups (based on the change of TyG-WHtR) and CVD. A restricted cubic spline (RCS) regression model was used to explore the potential nonlinear association of the cumulative TyG-WHtR and CVD events.

Results: During follow-up between 2015 and 2020, 623 (18.8%) of 3312 participants developed CVD. After adjusting for various potential confounders, compared to the participants with consistently low and stable TyG-WHtR, the risk of CVD was significantly higher in participants with moderate and increasing TyG-WHtR (OR 1.28, 95%CI 1.01-1.63) and participants with high TyG-WHtR with a slowly increasing trend (OR 1.58, 95%CI 1.16-2.15). Higher levels of cumulative TyG-WHtR were independently associated with a higher risk of CVD events (per SD, OR 1.27, 95%CI 1.12-1.43).

Conclusions: For middle-aged and older adults, changes in the TyG-WHtR are independently associated with the risk of CVD. Maintaining a favorable TyG index, effective weight management, and a reasonable waist circumference contribute to preventing CVD.

Citing Articles

Can cardiovascular health and its modifiable healthy lifestyle offset the increased risk of all-cause and cardiovascular deaths associated with insulin resistance?.

Qiu J, Li J, Xu S, Zeng H, Zhang Y, Yang S Cardiovasc Diabetol. 2025; 24(1):114.

PMID: 40065337 PMC: 11895255. DOI: 10.1186/s12933-025-02674-z.


Cholesterol, high-density lipoprotein, and glucose index versus triglyceride-glucose index in predicting cardiovascular disease risk: a cohort study.

Mo D, Zhang P, Zhang M, Dai H, Guan J Cardiovasc Diabetol. 2025; 24(1):116.

PMID: 40065297 PMC: 11895360. DOI: 10.1186/s12933-025-02675-y.


Comparison of triglyceride glucose index and modified triglyceride glucose indices in predicting cardiovascular diseases incidence among populations with cardiovascular-kidney-metabolic syndrome stages 0-3: a nationwide prospective cohort study.

Hong J, Zhang R, Tang H, Wu S, Chen Y, Tan X Cardiovasc Diabetol. 2025; 24(1):98.

PMID: 40022122 PMC: 11871812. DOI: 10.1186/s12933-025-02662-3.


The association between novel metabolic parameters and all-cause/cardiovascular mortality in patients with metabolic syndrome is modified by age.

Liu J, Fu Y, Liang P, Song Z, Li Y, Wu H Cardiovasc Diabetol. 2025; 24(1):96.

PMID: 40022121 PMC: 11871838. DOI: 10.1186/s12933-025-02587-x.


Insights into the complex relationship between triglyceride glucose-waist height ratio index, mean arterial pressure, and cardiovascular disease: a nationwide prospective cohort study.

Xu J, Cai D, Jiao Y, Liao Y, Shen Y, Shen Y Cardiovasc Diabetol. 2025; 24(1):93.

PMID: 40022080 PMC: 11871683. DOI: 10.1186/s12933-025-02657-0.


References
1.
Fuster J, Ouchi N, Gokce N, Walsh K . Obesity-Induced Changes in Adipose Tissue Microenvironment and Their Impact on Cardiovascular Disease. Circ Res. 2016; 118(11):1786-807. PMC: 4887147. DOI: 10.1161/CIRCRESAHA.115.306885. View

2.
Cui H, Liu Q, Wu Y, Cao L . Cumulative triglyceride-glucose index is a risk for CVD: a prospective cohort study. Cardiovasc Diabetol. 2022; 21(1):22. PMC: 8830002. DOI: 10.1186/s12933-022-01456-1. View

3.
Mensah G, Fuster V, Murray C, Roth G . Global Burden of Cardiovascular Diseases and Risks, 1990-2022. J Am Coll Cardiol. 2023; 82(25):2350-2473. PMC: 7615984. DOI: 10.1016/j.jacc.2023.11.007. View

4.
Butt J, Petrie M, Jhund P, Sattar N, Desai A, Kober L . Anthropometric measures and adverse outcomes in heart failure with reduced ejection fraction: revisiting the obesity paradox. Eur Heart J. 2023; 44(13):1136-1153. PMC: 10111968. DOI: 10.1093/eurheartj/ehad083. View

5.
Chen R, Zhan Y, Pedersen N, Fall K, Valdimarsdottir U, Hagg S . Marital status, telomere length and cardiovascular disease risk in a Swedish prospective cohort. Heart. 2019; 106(4):267-272. DOI: 10.1136/heartjnl-2019-315629. View